This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Filler Remove Genetics Remove Protein Related Topics
Genetic Engineering Cosmetics Dermatology Drug Delivery Insulin Hormones Nurses Packaging Doctors Containment More Related Topics >
article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

NOVEMBER 4, 2020

. Relying on independent research and development, the Company has formed gene recombination and fermentation engineering technology, and developed a number of core technologies, such as recombinant collagen, enzymatic and genetic engineering synthesis of bioactive peptides.

Licensing 40
Licensing Licensing Dermatology Production 40
article thumbnail

CarboFix

The Pharma Data

MAY 14, 2021

It’s all based on human biology… I refer to it as your “metabolism switch”… But the scientific name for it is AMP-activated protein kinase…. It’s the genetic master switch that controls our metabolism. …so you can see that there are no fillers…. How little you exercise….

Production 52
Production Insulin Packaging Packaging 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024